ArticleCurrent oncology (Toronto, Ont.)2023

Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety.

Saurav Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.